Exhaled nitric oxide measurement is useful for the exclusion of nonasthmatic eosinophilic bronchitis in patients with chronic cough

Chest

Volumn 134, Issue 5, 2008, Pages 990-995

  Oh, Mi Jung ^a   Lee, Jin Young ^b   Lee, Byung Jae ^b   Choi, Dong Chull ^b,c  

^a Bundang Jesaeng Hospital   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Samsung Medical Center   (South Korea)

Author keywords

Chronic cough; Eosinophil; Exhaled nitric oxide; Sputum

Indexed keywords

NITRIC OXIDE;

ADULT; ARTICLE; ASTHMA; BRONCHITIS; CHEMOLUMINESCENCE; CONTROLLED STUDY; COUGHING; DIAGNOSTIC TEST; EXHALATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONASTHMATIC EOSINOPHILIC BRONCHITIS; PRIORITY JOURNAL; ROC CURVE;

EID: 55849111544     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.07-2541     Document Type: Article

References (25)

1. Pratter MR. Overview of common causes of chronic cough: ACCP evidence-based clinical practice guidelines. Chest 2006; 129(suppl):59S-62S
2. Pratter MR, Brightling CE, Boulet LP, et al. An empiric integrative approach to the management of cough: ACCP evidence-based clinical practice guidelines. Chest 2006; 129(suppl):222S-231S
3. Hsu JY, Huang CM, King SL, et al. Importance of sputum differential cell counting in the diagnosis of airway diseases. J Formos Med Assoc 1997; 96:330-335
4. Gibson PG. How to measure airway inflammation: induced sputum. Can Respir J 1998; 5(suppl A):22A-26A
5. Brightling CE, Ward R, Goh KL, et al. Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med 1999; 160:406-410
6. Kharitonov SA, Gonio F, Kelly C, et al. Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children. Eur Respir J 2003; 21:433-438
7. Kharitonov SA. Exhaled markers of inflammatory lung diseases: ready for routine monitoring? Swiss Med Wkly 2004; 134:175-192
8. Dupont LJ, Rochette F, Demedts MG, et al. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroidnaive patients with mild asthma. Am J Respir Crit Care Med 1998; 157:894-898
9. Berlyne GS, Parameswaran K, Kamada D, et al. A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. J Allergy Clin Immunol 2000; 106:638-644
10. Chatkin JM, Ansarin K, Silkoff PE, et al. Exhaled nitric oxide as a noninvasive assessment of chronic cough. Am J Respir Crit Care Med 1999; 159:1810-1813
11. Kwon NH, Oh MJ, Min TH, et al. Causes and clinical features of subacute cough. Chest 2006; 129:1142-1147
12. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171:912-930
13. Fahy JV, Liu J, Wong H, et al. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. Am Rev Respir Dis 1993; 147:1126-1131
14. Iredale MJ, Wanklyn SA, Phillips IP, et al. Non-invasive assessment of bronchial inflammation in asthma: no correlation between eosinophilia of induced sputum and bronchial responsiveness to inhaled hypertonic saline. Clin Exp Allergy 1994; 24:940-945
15. Brightling CE. Chronic cough due to nonasthmatic eosinophilic bronchitis: ACCP evidence-based clinical practice guidelines. Chest 2006; 129(suppl):116S-121S
16. Birring SS, Berry M, Brightling CE, et al. Eosinophilic bronchitis: clinical features, management and pathogenesis. Am J Respir Med 2003; 2:169-173
17. Gibson PG, Dolovich J, Denburg J, et al. Chronic cough: eosinophilic bronchitis without asthma. Lancet 1989; 1:1346-1348
18. Brightling CE. Clinical applications of induced sputum. Chest 2006; 129:1344-1348
19. Belda J, Parameswaran K, Keith PK, et al. Repeatability and validity of cell and fluid-phase measurements in nasal fluid: a comparison of two methods of nasal lavage. Clin Exp Allergy 2001; 31:1111-1115
20. Wilson NM, Bridge P, Spanevello A, et al. Induced sputum in children: feasibility, repeatability, and relation of findings to asthma severity. Thorax 2000; 55:768-774
21. Fahy JV, Boushey HA, Lazarus SC, et al. Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study. Am J Respir Crit Care Med 2001; 163:1470-1475
22. Kharitonov SA, Yates D, Robbins RA, et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343:133-135
23. Kharitonov SA, Donnelly LE, Montuschi P, et al. Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma. Thorax 2002; 57:889-896
24. Silkoff PE, McClean P, Spino M, et al. Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients. Chest 2001; 119:1322-1328
25. Kharitonov SA, Yates DH, Barnes PJ. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996; 153:454-457